Abiopharma

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001839882-26-040763 <b>Size:</b> 450 KB

New Form FWP - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001918704-26-024331 <b>Size:</b> 90 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001918704-26-024330 <b>Size:</b> 549 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001839882-26-040758 <b>Size:</b> 974 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001918704-26-024329 <b>Size:</b> 906 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001140361-26-033798 <b>Size:</b> 311 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001918704-26-024328 <b>Size:</b> 921 KB

Quarter 2 / semi-annual report for 2026

(99% Neutral) PITNEY BOWES INC /DE/ (PBI) Files Form 8-K

The company’s liability position as of 30.6.26, by repayment dates

(99% Neutral) PERFORMANCE FOOD GROUP CO (PFGC) Announces Business Combination

The Honest Company Announces Participation in Upcoming Investor Conferences

LSI Industries Reports Fiscal 2026 Fourth Quarter and Full-Year Results and Declares Quarterly Cash Dividend

IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies

(99% Neutral) UROGEN PHARMA LTD. (URGN) Announces Business Combination